Peter Thiel backs Recharge Capital’s $200m women’s healthcare fund
Peter Thiel backs Recharge Capital’s $200m women’s healthcare fund Miguel Cordon
Peter Thiel / Photo credit: Dan Taylor
Recharge Capital, a private investment firm with offices in New York and Singapore, closed the first tranche of its US$200 million Women’s Healthcare Investment Vehicle.
The fund is backed by prominent investors such as Peter Thiel’s Thiel Capital, Shamrock Holdings of the Disney family, and the Olayan family of the Olayan Group.
The fund will find investment and roll-up opportunities in the women’s fertility value chain across Southeast Asia, Latin America, Europe, and the Middle East. Its efforts will focus on international fertility tourism, menstrual wellness, and women’s disease prevention.
Through the Women’s Healthcare Investment Vehicle, Recharge Capital aims to create an end-to-end ecosystem that integrates diagnostic solutions and seamless patient experiences through digital platforms and local clinic chains.
“Women’s healthcare, within our thematic-first investment framework, holds tremendous potential for both substantial growth and positive societal impact, as it addresses the needs of half of the global population,” said Lorin Gu, founding partner of Recharge Capital.
“Thematic-first” means that Recharge Capital targets startups whose services align with the niche themes listed on the VC firm’s website.
Recharge Capital was founded in 2016, scouting for deals in fintech, healthcare, and deep-tech enablement. One of its recent investments includes an incubation investment into Generation Prime, a digital healthcare platform set to provide the “first full-stack, closed-loop in-vitro fertilization (IVF) and related health services” through its clinics across Southeast Asia.
The women’s healthcare market is expected to reach US$63 billion by 2030, registering a compound annual growth rate of 5.4% in the next seven years.